Swiss National Bank’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$136M Buy
1,703,100
+94,300
+6% +$7.77M 0.08% 221
2025
Q4
$137M Sell
1,608,800
-82,200
-5% -$6.75M 0.08% 200
2025
Q3
$132M Sell
1,691,000
-82,100
-5% -$6.41M 0.08% 222
2025
Q2
$139M Buy
1,773,100
+109,600
+7% +$8.17M 0.08% 209
2025
Q1
$121M Sell
1,663,500
-38,300
-2% -$2.74M 0.09% 212
2024
Q4
$126M Sell
1,701,800
-86,800
-5% -$6.08M 0.08% 202
2024
Q3
$118M Buy
1,788,600
+8,300
+0.5% +$603K 0.08% 231
2024
Q2
$164M Sell
1,780,300
-36,000
-2% -$3.19M 0.11% 149
2024
Q1
$174M Sell
1,816,300
-84,700
-4% -$7.11M 0.12% 151
2023
Q4
$145M Sell
1,901,000
-48,900
-3% -$3.4M 0.11% 173
2023
Q3
$135M Sell
1,949,900
-239,100
-11% -$19.2M 0.11% 169
2023
Q2
$206M Sell
2,189,000
-264,600
-11% -$23M 0.14% 127
2023
Q1
$203M Sell
2,453,600
-66,000
-3% -$5.19M 0.14% 131
2022
Q4
$188M Sell
2,519,600
-174,825
-6% -$13.5M 0.14% 142
2022
Q3
$223M Sell
2,694,425
-9,800
-0.4% -$943K 0.16% 117
2022
Q2
$257M Buy
2,704,225
+100
+0% +$10.4K 0.17% 107
2022
Q1
$318M Buy
2,704,125
+334,900
+14% +$37.6M 0.18% 99
2021
Q4
$307M Sell
2,369,225
-88,800
-4% -$10.4M 0.18% 97
2021
Q3
$278M Sell
2,458,025
-88,500
-3% -$10.1M 0.18% 101
2021
Q2
$264M Buy
2,546,525
+149,716
+6% +$14.1M 0.16% 111
2021
Q1
$200M Buy
2,396,809
+48,600
+2% +$4.11M 0.13% 140
2020
Q4
$214M Sell
2,348,209
-63,800
-3% -$5.29M 0.15% 125
2020
Q3
$193M Sell
2,412,009
-64,900
-3% -$5.06M 0.15% 128
2020
Q2
$171M Buy
2,476,909
+48,400
+2% +$3.44M 0.14% 133
2020
Q1
$153M Buy
2,428,509
+461,400
+23% +$33.3M 0.16% 132
2019
Q4
$153M Sell
1,967,109
-98,400
-5% -$7.68M 0.16% 134
2019
Q3
$151M Buy
2,065,509
+31,515
+2% +$2.21M 0.16% 136
2019
Q2
$125M Sell
2,033,994
-59,100
-3% -$3.57M 0.14% 161
2019
Q1
$133M Buy
2,093,094
+51,000
+2% +$2.91M 0.15% 148
2018
Q4
$104M Buy
2,042,094
+23,100
+1% +$1.17M 0.13% 162
2018
Q3
$117M Sell
2,018,994
-64,800
-3% -$3.17M 0.13% 168
2018
Q2
$101M Buy
2,083,794
+47,100
+2% +$2.2M 0.12% 186
2018
Q1
$94.7M Sell
2,036,694
-299,400
-13% -$13M 0.12% 190
2017
Q4
$87.8M Buy
2,336,094
+10,500
+0.5% +$385K 0.09% 226
2017
Q3
$84.7M Sell
2,325,594
-2,100
-0.1% -$80.1K 0.1% 227
2017
Q2
$91.7M Buy
2,327,694
+55,200
+2% +$2.01M 0.11% 208
2017
Q1
$71.3M Buy
2,272,494
+493,500
+28% +$15.5M 0.09% 241
2016
Q4
$55.6M Buy
1,778,994
+12,300
+0.7% +$399K 0.09% 250
2016
Q3
$71M Sell
1,766,694
-38,100
-2% -$1.43M 0.11% 202
2016
Q2
$60M Buy
1,804,794
+123,300
+7% +$4.22M 0.1% 234
2016
Q1
$47.4M Buy
1,681,494
+513,900
+44% +$14.2M 0.09% 257
2015
Q4
$30.7M Buy
1,167,594
+15,900
+1% +$413K 0.07% 282
2015
Q3
$27.3M Buy
1,151,694
+109,200
+10% +$2.64M 0.07% 298
2015
Q2
$24.7M Buy
1,042,494
+64,800
+7% +$1.46M 0.06% 323
2015
Q1
$23.2M Buy
977,694
+387,600
+66% +$8.7M 0.06% 333
2014
Q4
$12.5M Sell
590,094
-19,800
-3% -$398K 0.05% 372
2014
Q3
$10.4M Sell
609,894
-16,800
-3% -$265K 0.04% 413
2014
Q2
$8.97M Sell
626,694
-10,800
-2% -$146K 0.03% 472
2014
Q1
$7.88M Sell
637,494
-79,800
-11% -$921K 0.03% 496
2013
Q4
$7.86M Sell
717,294
-16,200
-2% -$183K 0.03% 507
2013
Q3
$8.51M Buy
733,494
+4,800
+0.7% +$56.2K 0.04% 467
2013
Q2
$8.16M Buy
+728,694
New +$8.63M 0.04% 446

Other funds holding EW